| Stage | RRR | % of rev | MAR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $510M | 100.00% | $7.0B | 100.00% | MAR ×13.73 |
| Gross profit | $315M | 61.83% | $1.5B | 22.03% | RRR +39.8pp |
| Operating income | $136M | 26.65% | $1.3B | 18.19% | RRR +8.5pp |
| Pre-tax income | $90M | 17.65% | $1.1B | 15.13% | RRR +2.5pp |
| Net income | $77M | 15.01% | $794M | 11.33% | RRR +3.7pp |
| Stage | RRR | MAR | Gap · A − B |
|---|---|---|---|
| Revenue | $510M100.00% | $7.0B100.00% | MAR ×13.73 |
| Gross profit | 61.83%$315M | 22.03%$1.5B | RRR +39.8pp |
| Operating income | 26.65%$136M | 18.19%$1.3B | RRR +8.5pp |
| Pre-tax income | 17.65%$90M | 15.13%$1.1B | RRR +2.5pp |
| Net income |
| 15.01%$77M |
| 11.33%$794M |
| RRR +3.7pp |
No shared counterparties.